- CFO Spotlights
- Profiles
- Scott T. Reents
Profile
Scott T. Reents
Executive Vice President, Chief Financial Officer (Principal Financial Officer), AbbVie Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Scott T. Reents signed the annual report of AbbVie Inc. as Executive Vice President, Chief Financial Officer (Principal Financial Officer); the report was filed on February 20, 2026, the most recent filing in the record that ties Scott T. Reents to the seat.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| AbbVie Inc. (ABBV) Pharmaceutical Preparations | Executive Vice President, Chief Financial Officer (Principal Financial Officer) | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- February 20, 202610-K filed
Scott T. Reents signed the annual report of AbbVie Inc. on Form 10-K as Executive Vice President, Chief Financial Officer (Principal Financial Officer), filed February 20, 2026.
/s/ SCOTT T. REENTS Robert A. Michael Chairman of the Board and Chief Executive Officer (Principal Executive Officer) Scott T. Reents Executive Vice President, Chief Financial Officer (Principal Financial Officer)
[1] Annual report on Form 10-K by AbbVie Inc., filed with the SEC on February 20, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, AbbVie Inc.. U.S. Securities and Exchange Commission, EDGAR, filed February 20, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Scott T. Reents wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.